Collectively, these results clearly demonstrate the involvement of acetyltransferase p300 in positive regulator myocardin- and negative regulator IRF9-modulated cardiac hypertrophy in response to ventricular pressure overload. Here, MYOCD is linked to cardiac hypertrophy.